C ongenital long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT) are 2 genetic disorders of heart rhythm that may present during childhood and cause life-threatening cardiac arrhythmias. 1 The molecular mechanisms underlying arrhythmia susceptibility have been inferred from studies of mutant gene products, which are largely ion channels or channel regulators. In LQTS, loss of function in potassium channels or gain of function in either Na or Ca 2+ channels represent the major molecular mechanisms. In contrast to disturbances in plasma membrane ion channel function, CPVT arises from disordered intracellular Ca 2+ regulation, most frequently because of mutation of the ryanodine receptor Ca 2+ -release channel of the sarcoplasmic reticulum (SR). These advances have improved our understanding of arrhythmogenesis in general and have revealed new therapeutic targets. Recently, recurrent cardiac arrest in infants with a severe form of LQTS was associated with mutations in CALM1 (D130G, F142L) or CALM2 (D96V), 2 genes encoding the ubiquitous Ca 2+ -signaling protein calmodulin (CaM). 2 Independently, 2 distinct CaM mutations (N54I, N98S) were discovered in subjects with a CPVT-like syndrome although one of these mutations (N98S) has also been identified in a subject with LQTS. 3 Most of the mutations affect conserved amino acid residues that are known to participate in Ca 2+ binding or in energetic coupling of ion binding to CaM activation. Biochemical studies revealed that most CaM mutations, except N54I, cause reduced Ca 2+ -binding affinity. 2, 4 However, the cellular basis for arrhythmogenesis in the setting of CaM mutations has not been elucidated. CaM controls a large number of enzymes, ion channels, and other proteins. 5 In 6 This process, known as Ca 2+ -dependent inactivation (CDI), is a major determinant of cardiac excitability. 7 Engineered CaM with carboxyl lobe (C-lobe) mutations abrogating C-lobe Ca 2+ binding attenuated CDI and prolonged action potential (AP) duration. 7 The majority of the z-line CaM also binds to ryanodine receptor 2 (RyR2), 8 and CaM inhibits RyR2 openings independent of Ca 2+ concentration. 9, 10 Disrupting
CaM-RyR2 interaction has multiple effects including increased opening of RyR2, diminished I Ca,L , and increased cytosolic Ca 2+ at negative membrane potentials, creating a molecular substrate for arrhythmogenic triggers.
11 Consequently, at the cellular level, we anticipate that CaM mutants targeting CDI will have distinct effects from those disrupting CaM-RyR2 interactions. Most recently, CPVT-CaMs were shown to cause arrhythmogenic Ca 2+ disturbances in permeabilized cardiomyocytes that were distinct from LQTCaM-provoked alterations. 12 In this study, we examined the effects of LQTS-associated CaM mutations on Na and Ca 2+ channel currents to elucidate cellular and molecular mechanisms underlying arrhythmia predisposition. We found that CaM mutations had inconsistent effects on Na channels but caused impaired CDI of I Ca,L in cardiomyocytes and dysregulation of cytosolic Ca 2+ . In parallel, we examined the impact of the CPVT-associated mutation, N54I, on I Ca,L and observed no direct effects on LTCC current in cardiomyocytes; however, this mutation caused significant abnormalities in Ca 2+ homeostasis. Our findings implicate different molecular substrates for arrhythmogenesis associated with CaM mutations.
Methods
All experimental procedures and protocols involving animals were approved by the animal care and use committee of the University of Kentucky and conformed to the NIH Guide for Care and Use of Laboratory Animals. Isolated fetal ventricular cardiomyocytes (FVM) were prepared as previously described, 13 except embryonic day 18 to 19 pregnant dams were used.
Mutagenesis of Calmodulin
Mutant CaMs were engineered by making one of the following amino acid substitutions: N54I, D96V, N98S, D130G, or F142L. A mammalian expression plasmid was used to drive expression of wild-type (WT) or mutant CaM by the immediate early CMV promoter along with the coding region for either green fluorescent protein or CD8 preceded by the IRES2 element as cotransfection markers.
Heterologous Expression of Human Na V 1.
With Calmodulin
Plasmids encoding recombinant human cardiac Na channel isoforms (Na V 1.5) were described previously. 14 For studies of Na channel function, WT cardiac Na channel cDNA (0.5 lg) and WT or mutant CaM (D130G, D96V, and F142L) cDNA (0.5 lg) in vectors encoding the cotransfection marker CD8 were transiently transfected into tsA201 cells using FuGene HD (Roche Diagnostics, Indianapolis, IN), then incubated for 48 hours at 37°C prior to electrophysiological measurements. Dynabeads-CD8 (Invitrogen Life Technologies, Carlsbad, CA) were added to cell culture media according to manufacturer's instructions to mark cells transfected successfully. Cells selected for patch clamp recordings exhibited CD8 expression with Dynabeads attached to the cell surface and were easily distinguishable from non-CD8-expressing cells.
Fetal Ventricular Myocyte Tissue Harvest or Cell Culture
Hearts of embryonic day 18 to 19 (a fetal stage) mouse (ICR outbred strain; Harlan Laboratories) were dissected free of connective tissues, and ventricles were separated from atria. Cells were enzymatically dispersed and cultured as previously described. 15 Briefly, about 10 fetuses were minced and quickly transferred to nominally Ca 2+ -free digestion buffer containing 0.5 mg/mL collagenase (type II; Worthington Biochemical Corporation) and 1 mg/mL pancreatin for two 15-minute cycles. Digested tissue yielded a large fraction of single spontaneously beating cells in culture media consisting of DMEM plus 10% FBS. Cells were transfected in 24-well plates using Lipofectamine transfection reagent (Invitrogen Life Technologies). Cells were transfected with plasmids given above and used 24 to 48 hours after transfection. FVM were selected for study based on enhanced green fluorescent protein fluorescence unless otherwise noted.
viously. 14, 16 The extracellular bath solution contained the following (in millimoles per liter): 140 NaCl, 4 KCl, 1. 
Statistical Analysis
Data were analyzed for Figures 5C, 6B , 7B, and 7D with the chi-square test. Figure 9A was analyzed with 1-way ANOVA with Dunn's multiple comparison test. Figure 9A and the remaining data analysis passed the D'Agostino and Pearson test and the Shapiro-Wilk test for normality, and tests of statistical difference for the remaining data were performed using the t test with statistical significance correction of multiple comparisons and a=0.05 using the Holm-Sidak method in GraphPad Prism version 6.0 for Windows (GraphPad Software, La Jolla, CA).
Results

Effect of CaM Mutants on Cardiac Na Channels
Because CaM is known to regulate cardiac Na channel inactivation and a specific defect in Na channel inactivation (increased persistent Na current) occurs in LQTS, 19 we investigated the effects of LQTS-CaM mutants on heterologously expressed Na V 1.5 as well as on native Na current. We performed heterologous coexpression of WT or mutant CaM with human Na V 1.5 in tsA201 cells and then measured electrophysiological properties of the expressed channels. When recording Na current with a nominally Ca 2+ -free intracellular solution, we did not observe differences in the level of persistent Na current (expressed as a percentage of peak current) for any of the CaM mutations compared with WT CaM. Consequently, we repeated these experiments with elevated intracellular calcium (~1 lmol/L free Ca 2+ ) to provide a saturating concentration of Ca 2+ to promote binding of CaM to Na V 1.5. 2, 17 Furthermore, because of the early age of onset of LQTS in the reported probands, we also tested the effects of CaM mutations on a fetal and neonatal-expressed Na V 1.5 splice variant. 14 Cells coexpressing CaM-D130G with fetal Na V 1.5 exhibited 7.5-fold larger persistent Na current (1.5AE0.4%) compared with cells coexpressing the fetal splice variant with WT CaM (0.2AE0.1%; P<0.05) when recordings were made with high intracellular calcium ( Figure 1A ). This greater level of persistent current was not observed when CaM-D130G was coexpressed with the canonical (adult expressed) splice isoform of Na V 1.5 or with low intracellular calcium ( Table 1 ). In contrast, cells coexpressing fetal or canonical Na V 1.5 splice isoforms with either CaM-D96V or CaM-F142L did not exhibit abnormal levels of persistent Na current under high calcium conditions (Table 1 ). Other Na channel properties including conductance-voltage relationship, voltage dependence of steady-state inactivation, inactivation kinetics, and recovery from inactivation were largely unaffected by CaM mutants (Table 2) . Furthermore, expression of CaM-D130G in mouse FVM did not evoke detectable differences in the level of persistent Na current compared with cells transfected with WT CaM ( Figure 1B ). Given the inconsistent effect of CaM mutants on heterologous and native Na current, we concluded that Na V 1.5 dysfunction was not the major cause of LQTS in the setting of CaM mutations.
CDI is Slowed by LQTS-CaM But Not by a CPVTAssociated CaM Mutant
We tested the hypothesis that LQTS-CaM mutations with impaired C-domain Ca 2+ affinity will slow I Ca,L decay in a native cardiomyocyte environment due to impaired CDI. . Long QT syndrome (LQTS) CaM mutation effects on persistent Na current are limited to a single splice variant of Na V 1.5 and a single CaM mutation. A, CaM-D130G evoked increased persistent sodium current with fetal Na V 1.5. Averaged tetrodotoxin-sensitive currents were normalized to the peak current measured at À30 mV during a 200-ms depolarization recorded under high intracellular Ca 2+ concentration (see Methods). The inset represents the same data plotted on an expanded vertical scale. Summary data are provided in Table 1 . B, CaM-D130G has no significant effect on persistent Na current in fetal ventricular cardiomyocytes. Tetrodotoxin-sensitive currents were normalized to the peak current measured at À30 mV during a 300-ms depolarization recorded under high intracellular Ca 2+ concentration (see Methods). The inset represents the same data plotted on an expanded vertical scale. CaM indicates calmodulin; WT, wild type.
not different between FVM expressing WT or LQTS-CaM mutants ( Figure 3 ; Table 3 ). In contrast, the CPVT-association CaM mutation N54I did not significantly affect CDI (Figure 4 ). These data suggest that attenuated CDI and resulting slower I Ca,L decay can contribute to mutant CaM-associated LQTS but not CPVT.
Rate Dependence of Entrainment to Field Stimulation
Field stimulation of FVM causes a Ca 2+ -induced Ca 2+ release that follows a fire-diffusion-fire paradigm qualitatively similar to that of mature cardiomyocytes. 20 
LQTS-CaM Mutations Perturb Ca 2+ Handling
We investigated whether elevation of cytosolic Ca 2+ could drive the loss of entrainment induced by LQTS-CaM mutants ( Figure 6 ). FVM expressing LQTS-CaM mutations have significantly higher twitch amplitude than cells expressing WT CaM ( Figure 8A) . Notably, the mean twitch amplitude for D130G is less than that for F142L and D96V. Similarly, diastolic Ca stores. Consequently, we probed the contribution of LQTS-CaM mutation to SR Ca 2+ load by assessing caffeinereleasable Ca 2+ stores ( Figure 8C ). The mean SR Ca 2+ appears greater in LQTS-CaM mutant expressing cardiomyocytes compared with cells expressing WT CaM, but the differences did not reach statistical significance ( Figure 8D) . Examination of the decay of caffeine-induced Ca 2+ transient reveals no significant difference for any of the LQTS-CaM mutants ( Figure 8E ). This suggests that Na + /Ca 2+ exchange (NCX) function is not altered by LQTS-CaM mutations. These results are consistent with the model that LQTS-CaM mutant promoter increased trigger Ca 2+ from the slowed decay of I Ca, L . NCX is the main surface membrane efflux pathway, thus more LTCC Ca 2+ influx paired with unchanged NCX-based efflux could lead to elevated cytosolic Ca 2+ .
Isoproterenol Restores Entrainment for LQTSCaM Mutations
The LQTS-CaM mutants D96V and D130G cause abnormal Ca 2+ transients at elevated stimulation frequencies (Figures 4 and 5) and exhibit elevated cytosolic Ca 2+ levels ( Figure 8 ).
Higher Ca 2+ levels could drive arrhythmogenic activity analogous to that seen for CPVT. 21 Faster pacing rates protect against catecholamine-induced triggered activity in CPVT models 22 ; however, Ca 2+ -transient abnormalities are exacerbated at even modestly higher rates (≥1 Hz) in FVM expressing relatively low Ca 2+ -affinity LQTS-CaM mutants For clarity, the WT CaM data are illustrated along with each LQTS-CaM mutation plot. **P<0.01; ****P<10 À4 . CDI indicates Ca 2+ -dependent inactivation; WT, wild type.
expressing LQTS-CaM mutants ( Figure 9A and 9Ai) . Given the propensity of defective Ca 2+ reuptake observed in D96V
and D130G-CaM expressing cardiomyocytes, we tested the hypothesis that ISO treatment alleviates these LQTS-CaM mutant-induced Ca 2+ -transient loss of entrainment. Figure 9B shows a representative D96V-CaM-expressing cardiomyocyte.
Prior to ISO addition, a 2:1 block occurs ( Figure 9B , upper left). ISO induces a partial rescue of 1:1 entrainment manifested as a spontaneous transition from 2:1 to 1:1 (stimulus to Ca 2+ transient; Figure 9B , upper right). This type of behavior was scored as "partial rescue" because of spontaneous restoration and reversion of pathological Ca Overall, ISO caused some degree of restoration of normal Ca 2+ homeostasis in 65% of cells tested. For D96V-CaMexpressing cardiomyocytes, 9 and 2 of 17 cells showed partial and full restoration, respectively. For D130G-CaM-expressing cardiomyocytes, 4 and 3 of 11 cells showed partial and full restoration, respectively. In sharp contrast, acute ISO led to cell death in 6 of 9 CPVT-CaM mutant-expressing cardiomyocytes and had no beneficial effects in the remaining cells Table 3 for Boltzmann distribution fitted parameters. WT indicates wild type. tested. These data suggest that slowed Ca 2+ reuptake contributes to LQTS-CaM-associated arrhythmogenesis, and enhancing the rate of reuptake is a plausible mechanism for ameliorating LQTS-CaM dysfunction.
Discussion
The major new finding of this study is that CaM mutants associated with LQTS cause significantly slowed CDI of I Ca,L Higher stimulus frequency evoked a greater prevalence of escape events in rank order with Ca 2+ -CaM affinity. For statistical testing, we lumped together escape events at 2 and 3 Hz, P<10
À4 . CaM indicates calmodulin; WT, wild type. and alter Ca 2+ homeostasis in FVM. We also excluded a major contribution of dysregulated Na current caused by LQTS-CaM mutations. In contrast, the CPVT-CaM mutant N54I had no effect on CDI but disrupted Ca 2+ homeostasis. We conclude that LQTS-CaM evokes the novel mechanism of CDI slowing to initiate the sequence of cellular physiological events leading to ventricular arrhythmia. This study shows a rank-order relationship between Ca 2+ -CaM affinity and the propensity for abnormal Ca 2+ homeostasis. This relationship holds for the 3 tested LQTSCaM mutants and is distinct for CPVT-CaM mutant N54I. LQTS is driven by a prolongation of the ventricular cellular AP duration, and AP duration is determined by the sum of ionic conductance, principally net voltage-gated K + channels and 
Study Limitations
For heterologous expression of Na V 1.5 we selected 2 prominently expressed products of alternative splicing: the canonical form expressed in adult heart and a developmentally regulated splice variant that is expressed prominently in fetal and infant heart. Evidence exists for protein expression of both splice isoforms. Other SCN5A splice variants have been demonstrated at the mRNA level but not at the protein level, and their developmental regulation is uncertain. The most straightforward interpretation of our Na V 1.5 data is that augmentation of late I Na is not to the main pathophysiological mechanism responsible for the LQTS-CaM phenotype; however, we cannot exclude that another unstudied splice variant conspires with mutant CaM to evoke a pathological phenotype. In contrast, our data on Ca 2+ channel modulation argues effectively that delayed CDI is a more plausible mechanism for LQTS associated with CaM mutations. Relatively late development stage FVM served as a cellular model to study the effects of LQTS-CaM-associated mutations. These late-stage FVM express a full complement of mature cardiomyocyte physiological responses including Ca 2+ -induced Ca 2+ release 20, 33 and b-adrenergic receptormediated responses. 34, 35 As with any cellular system, there are limitations. First, although the LTCC multiprotein complex is fully functional, the same issues discussed above for expression of various channel protein isoforms applies. Second, this is a cellular model, and behaviors of dispersed cells may not report native physiological responses. Although this system allows us to use a common background to compare the influence of CaM mutations, it will be important to follow up studies in more complex in vivo settings. In summary, LQTS-and CPVT-associated CaM mutations both disrupt Ca 2+ homeostasis in murine cardiomyocytes, but there is a sharp dichotomy in pathways leading to pathological phenotypes. LQTS-CaM mutations occurring on the C-lobe of CaM reduce Ca 2+ affinity and, consequently, cause slowing of LTCC kinetics by attenuating CDI. In contrast, CPVT-CaM mutant N54I has no effect on LTCC kinetics. As expected for CPVT, b-adrenergic stimulation irreversibly overloaded cytosolic Ca 2+ but also partially restored entrainment. This suggests a potential proof of principle for genotype-specific treatment of "calmodulinopathies."
